The Chairman of the FSMA, Jean-Paul Servais, was invited by the European Commission to speak at a panel discussion organized as part of a roundtable on the review of the Benchmark Regulation (BMR). The subject of the discussion was the IBOR review and the extent to which the framework created for the BMR gives supervisory […]
The Chairman of the FSMA, Mr Jean-Paul Servais, gave a speech at the Investment Management Forum organized by EFAMA (European Fund and Asset Management Association). During his remarks, the Chairman stressed the importance of financial education. He also outlined the initiatives that the FSMA has already taken via its financial education programme, Wikifin, and in […]
The Financial Services and Markets Authority (FSMA) hereby announces that the modified market rules of the regulated markets organized by Euronext NV/SA (namely Euronext Brussels and the Euronext Brussels Derivative Instruments Market) were approved on 19 November 2019 in accordance with Article 34, § 1 of the Law of 21 November 2017 on the market […]
This press release is not available in English, please consult the French or Dutch site. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT biotech, ISIN BE0974289218 on Euronext Brussels will re-open on 25/11/2019 at 09:00 CET. Source: FSMA
This press release is not available in English. Please consult the French or Dutch site. Source: FSMA